急性肺栓塞极早期大出血风险预测:肺栓塞-晕厥、贫血与肾功能不全(PE-SARD)出血评分的独立外部验证
在687例年龄≥65岁的急性肺栓塞前瞻性多中心瑞士队列中独立验证PE-SARD出血评分,该评分将患者分为低、中、高危三组。7天极早期大出血发生率为2.0%(14/687),低、中、高危组分别为1.8%、2.1%、2.5%;7天曲线下面积为0.52(95% CI,0.48-0.56),随访结束时升至0.60(95% CI,0.56-0.64),评分校准良好(p > .05)。结论认为PE-SARD评分不能准确预测极早期大出血,可能不适用于老年肺栓塞患者。
要点
- PE-SARD评分在687例年龄≥65岁急性肺栓塞患者中7天大出血预测的曲线下面积为0.52(95% CI,0.48-0.56)。
- 7天极早期大出血发生率低危组1.8%、中危组2.1%、高危组2.5%。
- 评分校准良好(p > .05),但区分度不足以准确预测极早期大出血。
核心结论
- 在该独立验证中,PE-SARD评分不能准确预测极早期大出血,可能不适用于老年肺栓塞患者。
研究设计与样本
- 前瞻性多中心瑞士队列,纳入687例年龄≥65岁的急性肺栓塞患者,独立验证PE-SARD出血评分。
- PE-SARD评分基于晕厥、贫血和肾功能不全3个变量,将患者分为低、中、高危3个出血风险类别。
- 主要结局为7天极早期大出血,次要结局为后续时间点的大出血;采用受试者工作特征曲线下面积评估区分度,Hosmer-Lemeshow拟合优度检验评估校准度。
主要发现
- 7天大出血发生率为2.0%(14/687),中位随访30个月后大出血发生率为14.0%(96/687)。
- PE-SARD评分将40.2%、42.2%、17.6%的患者分别归为低、中、高危组。
- 7天观察到的极早期大出血发生率低危组为1.8%、中危组为2.1%、高危组为2.5%。
- 7天曲线下面积为0.52(95% CI,0.48-0.56),随访结束时升至0.60(95% CI,0.56-0.64)。
- 整个随访期间评分校准良好(p > .05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction (PE-SARD) bleeding score was derived to predict very early major bleeding (MB) in patients with acute pulmonary embolism (PE). Before adoption into practice, the score requires external validation in different populations. OBJECTIVES: We independently validated the PE-SARD score in a prospective multicenter Swiss cohort of 687 patients aged ≥65 years with acute PE. METHODS: The PE-SARD score uses 3 variables (syncope, anemia, and renal dysfunction) to classify patients into 3 categories of increasing bleeding risk. The outcomes were very early MB at 7 days (primary) and MB at later time points (secondary). We calculated the PE-SARD score for each patient and classified the proportion of patients as being at low, intermediate, and high risk. To assess discrimination and calibration, we calculated the area under the receiver operating characteristic curve and the Hosmer-Lemeshow goodness-of-fit test, respectively. RESULTS: The prevalence of MB was 2.0% (14/687) at 7 days and 14.0% (96/687) after a median follow-up of 30 months. The PE-SARD score classified 40.2%, 42.2%, and 17.6% of patients as low, intermediate, and high risk for MB, respectively. The frequency of observed very early MB at 7 days was 1.8% in low-, 2.1% in intermediate-, and 2.5% in high-risk patients. The area under the receiver operating characteristic curve was 0.52 (95% CI, 0.48-0.56) at 7 days and increased to 0.60 (95% CI, 0.56-0.64) at the end of follow-up. Score calibration was adequate (p > .05) over the entire follow-up. CONCLUSION: In our independent validation, the PE-SARD score did not accurately predict very early MB and may not be transportable to older patients with PE.
引用
- Villiger R, Méan M, Stalder O, et al. Prediction of very early major bleeding risk in acute pulmonary embolism: an independent external validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction (PE-SARD) bleeding score. J Thromb Haemost. 2023. PMID: 37149148. doi:10.1016/j.jtha.2023.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。